Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity - PubMed (original) (raw)
. 2007 Jan;88(Pt 1):242-250.
doi: 10.1099/vir.0.82125-0.
Affiliations
- PMID: 17170457
- DOI: 10.1099/vir.0.82125-0
Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity
Cristina Cerboni et al. J Gen Virol. 2007 Jan.
Abstract
Natural killer (NK) cells are a major component of the host innate immune defence against various pathogens. Several viruses, including Human immunodeficiency virus 1 (HIV-1), have developed strategies to evade the NK-cell response. This study was designed to evaluate whether HIV-1 could interfere with the expression of NK cell-activating ligands, specifically the human leukocyte antigen (HLA)-I-like MICA and ULBP molecules that bind NKG2D, an activating receptor expressed by all NK cells. Results show that the HIV-1 Nef protein downmodulates cell-surface expression of MICA, ULBP1 and ULBP2, with a stronger effect on the latter molecule. The activity on MICA and ULBP2 is well conserved in Nef protein variants derived from HIV-1-infected patients. In HIV-1-infected cells, cell-surface expression of NKG2D ligands increased to a higher extent with a Nef-deficient virus compared with wild-type virus. Mutational analysis of Nef showed that NKG2D ligand downmodulation has structural requirements that differ from those of other reported Nef activities, including HLA-I downmodulation. Finally, data demonstrate that Nef expression has functional consequences on NK-cell recognition, causing a decreased susceptibility to NK cell-mediated lysis. These findings provide a novel insight into the mechanisms evolved by HIV-1 to escape from the NK-cell response.
Similar articles
- The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR.
Matusali G, Potestà M, Santoni A, Cerboni C, Doria M. Matusali G, et al. J Virol. 2012 Apr;86(8):4496-504. doi: 10.1128/JVI.05788-11. Epub 2012 Feb 1. J Virol. 2012. PMID: 22301152 Free PMC article. - Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C. Rölle A, et al. J Immunol. 2003 Jul 15;171(2):902-8. doi: 10.4049/jimmunol.171.2.902. J Immunol. 2003. PMID: 12847260 - HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
Fausther-Bovendo H, Sol-Foulon N, Candotti D, Agut H, Schwartz O, Debré P, Vieillard V. Fausther-Bovendo H, et al. AIDS. 2009 Jun 1;23(9):1077-87. doi: 10.1097/QAD.0b013e32832cb26b. AIDS. 2009. PMID: 19424050 - Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Giuliani E, Vassena L, Cerboni C, Doria M. Giuliani E, et al. Curr Drug Targets. 2016;17(1):54-64. doi: 10.2174/1389450116666150630110329. Curr Drug Targets. 2016. PMID: 26122035 Review. - The NKG2D receptor: sensing stressed cells.
López-Larrea C, Suárez-Alvarez B, López-Soto A, López-Vázquez A, Gonzalez S. López-Larrea C, et al. Trends Mol Med. 2008 Apr;14(4):179-89. doi: 10.1016/j.molmed.2008.02.004. Epub 2008 Mar 18. Trends Mol Med. 2008. PMID: 18353724 Review.
Cited by
- NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity.
Marchitto L, Tauzin A, Benlarbi M, Beaudoin-Bussières G, Dionne K, Bélanger É, Chatterjee D, Bourassa C, Medjahed H, Yang D, Chiu TJ, Chen HC, Iii ABS, Richard J, Finzi A. Marchitto L, et al. Viruses. 2024 Jul 20;16(7):1167. doi: 10.3390/v16071167. Viruses. 2024. PMID: 39066329 Free PMC article. - Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications.
Letafati A, Ardekani OS, Naderisemiromi M, Norouzi M, Shafiei M, Nik S, Mozhgani SH. Letafati A, et al. Virol J. 2024 Jan 12;21(1):18. doi: 10.1186/s12985-024-02287-0. Virol J. 2024. PMID: 38216935 Free PMC article. Review. - Harnessing immune cells to eliminate HIV reservoirs.
Grasberger P, Sondrini AR, Clayton KL. Grasberger P, et al. Curr Opin HIV AIDS. 2024 Mar 1;19(2):62-68. doi: 10.1097/COH.0000000000000840. Epub 2024 Jan 2. Curr Opin HIV AIDS. 2024. PMID: 38167784 Review. - Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?
Razizadeh MH, Zafarani A, Taghavi-Farahabadi M, Khorramdelazad H, Minaeian S, Mahmoudi M. Razizadeh MH, et al. Cell Commun Signal. 2023 Sep 25;21(1):261. doi: 10.1186/s12964-023-01266-2. Cell Commun Signal. 2023. PMID: 37749597 Free PMC article. Review. - Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity.
Marchitto L, Benlarbi M, Prévost J, Laumaea A, Descôteaux-Dinelle J, Medjahed H, Bourassa C, Gendron-Lepage G, Kirchhoff F, Sauter D, Hahn BH, Finzi A, Richard J. Marchitto L, et al. mBio. 2023 Aug 31;14(4):e0078923. doi: 10.1128/mbio.00789-23. Epub 2023 Jul 5. mBio. 2023. PMID: 37404017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials